0
settings
الوضع الليلي
moon
انماط الصفحة الرئيسية arrow
EN
1
المرجع الالكتروني للمعلوماتية

النبات

مواضيع عامة في علم النبات

الجذور - السيقان - الأوراق

النباتات الوعائية واللاوعائية

البذور (مغطاة البذور - عاريات البذور)

الطحالب

النباتات الطبية

الحيوان

مواضيع عامة في علم الحيوان

علم التشريح

التنوع الإحيائي

البايلوجيا الخلوية

الأحياء المجهرية

البكتيريا

الفطريات

الطفيليات

الفايروسات

علم الأمراض

الاورام

الامراض الوراثية

الامراض المناعية

الامراض المدارية

اضطرابات الدورة الدموية

مواضيع عامة في علم الامراض

الحشرات

التقانة الإحيائية

مواضيع عامة في التقانة الإحيائية

التقنية الحيوية المكروبية

التقنية الحيوية والميكروبات

الفعاليات الحيوية

وراثة الاحياء المجهرية

تصنيف الاحياء المجهرية

الاحياء المجهرية في الطبيعة

أيض الاجهاد

التقنية الحيوية والبيئة

التقنية الحيوية والطب

التقنية الحيوية والزراعة

التقنية الحيوية والصناعة

التقنية الحيوية والطاقة

البحار والطحالب الصغيرة

عزل البروتين

هندسة الجينات

التقنية الحياتية النانوية

مفاهيم التقنية الحيوية النانوية

التراكيب النانوية والمجاهر المستخدمة في رؤيتها

تصنيع وتخليق المواد النانوية

تطبيقات التقنية النانوية والحيوية النانوية

الرقائق والمتحسسات الحيوية

المصفوفات المجهرية وحاسوب الدنا

اللقاحات

البيئة والتلوث

علم الأجنة

اعضاء التكاثر وتشكل الاعراس

الاخصاب

التشطر

العصيبة وتشكل الجسيدات

تشكل اللواحق الجنينية

تكون المعيدة وظهور الطبقات الجنينية

مقدمة لعلم الاجنة

الأحياء الجزيئي

مواضيع عامة في الاحياء الجزيئي

علم وظائف الأعضاء

الغدد

مواضيع عامة في الغدد

الغدد الصم و هرموناتها

الجسم تحت السريري

الغدة النخامية

الغدة الكظرية

الغدة التناسلية

الغدة الدرقية والجار الدرقية

الغدة البنكرياسية

الغدة الصنوبرية

مواضيع عامة في علم وظائف الاعضاء

الخلية الحيوانية

الجهاز العصبي

أعضاء الحس

الجهاز العضلي

السوائل الجسمية

الجهاز الدوري والليمف

الجهاز التنفسي

الجهاز الهضمي

الجهاز البولي

المضادات الميكروبية

مواضيع عامة في المضادات الميكروبية

مضادات البكتيريا

مضادات الفطريات

مضادات الطفيليات

مضادات الفايروسات

علم الخلية

الوراثة

الأحياء العامة

المناعة

التحليلات المرضية

الكيمياء الحيوية

مواضيع متنوعة أخرى

الانزيمات

قم بتسجيل الدخول اولاً لكي يتسنى لك الاعجاب والتعليق.

Mismatch repair

المؤلف:  Katherine Floyd

المصدر:  Core Concepts in Biology: Molecular Biology

الجزء والصفحة:  2nd Edition , p89-99

2026-11-21

23

+

-

20

Mismatch repair is strand-specific. During DNA synthesis the newly synthesised (daughter) strand will commonly include errors. In order to begin repair, the mismatch repair machinery distinguishes the newly synthesised strand from the template (parental). In gram-negative bacteria, transient hemimethylation distinguishes the strands (the parental is methylated and daughter is not).

The mismatch repair (MMR) system is essential to all organisms because it maintains the stability of the genome during repeated duplication. It is composed of a few well-conserved proteins whose functions in the postreplicative repair of mismatched DNA have been characterized by co-ordinated genetic, biochemical and structural approaches. Various functions, in addition to mismatch repair during replication, have been reported for MMR proteins such as antirecombination activity between divergent sequences, promotion of meiotic crossover, DNA damage surveillance and diversification of immunoglobulins (Figure 1). Recent research has provided a great deal of information about how MMR proteins are involved in these diverse processes.

Fig1. Various functions of mismatch repair (MMR) proteins.

MMR proteins are involved in diverse genetic pathways through interactions with different proteins. MMR proteins increase replication fidelity by repairing errors generated during replication. Proliferating cell nuclear antigen (PCNA) and replication factor C (RFC) work with MMR proteins during mismatch repair in replication. Various kinds of DNA damage trigger MMR proteindependent DNA damage responses that are implemented through the activation of ataxia telangiectasia mutated and Rad3-related (ATR) and p53. Antibody diversification is formed by mutations in immunoglobulin genes that are introduced by MMR proteins in conjunction with activation-induced cytidine deaminase (AID) and DNA polymerase g. In addition, MMR proteins regulate recombination and promote meiotic crossover.

Prokaryotic mismatch repair

Essential components of the MMR system – MutS, MutL, MutH and Uvr – were identified in Escherichia coli through the genetic studies of mutants that showed elevated mutation levels. MMR reactions have also been reconstituted with purified components in E. coli, which drove extensive studies on prokaryotic MMR systems.

MutS detects mismatches in DNA duplexes and initiates the MMR machinery. A microscopic suggested a possible mechanism for how MutS discriminates between heteroduplex and homoduplex DNA. According to this proposal, nonspecifically bound MutS bends DNA to search for a mismatch. If it recognizes a specific mismatch, MutS undergoes a conformational 91 change and unbends the bent DNA. Crystallographic studies of Thermus aquaticus and E. coli MutS complexed with mismatched DNA provided the molecular details of mismatch recognition, suggesting that a homodimer of MutS binds asymmetrically to heteroduplex DNA (Figure 2A).

Fig2. Structures of MutS, MutL and MutH.

(A) Crystal structure of the Thermus aquaticus MutS heteroduplex DNA complex (PDB accession code: 1EWQ). The MutS homodimer is formed by asymmetric subunits that are represented by ribbon diagrams in green and purple. The heteroduplex DNA is a space-filling model. Two adjacent large channels with dimensions of ~ 30 × 20 A˚ and ~ 40 × 20 A˚ penetrate the disk-like protein structure, and the latter is occupied by the heteroduplex DNA. The DNA is kinked sharply towards the major groove by ~ 60 ˚ at the unpaired base. Only one subunit (in purple) interacts with the unpaired base, thereby breaking the molecular twofold symmetry of the homodimer. (B) Crystal structure of the N-terminal 40 kDa fragment (LN40) of Escherichia coli MutL complexed with ADPnP (PDB accession code: 1B63). The structure of LN40 is homologous to that of an ATPase-containing fragment of DNA gyrase. ADPnP drives the dimerization of LN40, and the dimer interface is well ordered and made entirely of the segments that were disordered in the apoprotein. (C) A crystal structure of MutH (PDB accession code: 1AZO). The structure resembles a clamp, with a large cleft dividing the molecule into two halves. Each half forms a subdomain that contains similar structural elements. The two subdomains share a hydrophobic interface and are connected by three polypeptide linkers. The active site is located at an interface between two subdomains, and DNA binds in the cleft that is 15–18 A˚ wide and 12–14 A˚ deep.

MutS has two functional domains (a DNA-binding domain and an ATPase ⁄ dimerization domain) and the asymmetry in the ATPase ⁄ dimerization domain was also reported to be essential in the MMR process in vivo. These two domains are widely separated from each other, but affect each other by conformational changes that are induced by the binding of DNA or ATP. This interaction is a key molecular mechanism for modulating the function of the MutS protein in the MMR process. DNA Repair Only two residues, both in the same subunit of MutS, take part in the sequence-specific interaction with a mismatched base. One, a conserved glutamate (Glu41 in T. aquaticus MutS and Glu38 in E. coli MutS), forms a hydrogen bond with the mismatched base. Recently, this hydrogen bond was suggested to induce an inhibition of the ATPase activity of MutS, helping to form a stable MutS–ATP–DNA intermediate of the downstream repair process. The other specific interaction is between an aromatic ring stack of a conserved phenylalanine (Phe39 in T. aquaticus MutS and Phe36 in E. coli MutS) and the mismatched base. In contrast to these sequence–specific interactions, van der Waals interactions and hydrogen bonds between the DNA backbone and side chains of MutS are sequence independent. After the recognition of mismatched DNA, MutS initiates the MMR system through direct or indirect interactions with other proteins, including MutL, MutH and UvrD. Although an exact answer to this puzzle is yet to be found, a few groups have suggested various models for detailed molecular events during MMR reactions (Figure 3).

Fig3. Models for the assembly of the DNA mismatch repair complex in a schematic drawing.

A mismatch base is detected by MutS, and ATP-bound MutS recruits MutL. In model I, the MutS–MutL complex stays at the mismatch site and activates MutH at some distance. MutS leaves the mismatch site, after binding ATP, in both model II and model III. ATP is used as an energy source for translocation of MutS in model II (translocation model) but it acts as a molecular switch of MutS in model III, like GTP of G-proteins (molecular switch model).

The function of MutL in the MMR system is to make a connection between the recognition of a mismatch and the excision of the mismatch from the strand within which it is contained. To do this, a MutL homodimer interacts with MutS and stimulates the endonuclease activity of MutH. MutL also loads UvrD onto the DNA. UvrD is a DNA helicase II that unwinds the DNA duplex from the nick generated by MutH. MutL is a member of the GHKL superfamily of ATPases, which includes gyrase, a type II topoisomerase, Hsp90, histidine kinase and MutL. A biochemical demonstrated that MutL has ATPase activity. Crystallographic studies have demonstrated that ATP binding drives dimerization of the N-terminal domain of the protein (Figure 2B), and the accompanying structural changes may play key roles in co-ordinating the initial steps of mismatch recognition with downstream processing steps. A model for the intact MutL protein, which includes a large central cavity, was suggested based on the structures of the N-terminal domain (LN40) and the C-terminal domain (LC20), which were reported separately. A biochemical assay, using various mutant MutL proteins, suggested that LC20 is involved in the DNA-binding activity of MutL. An increase in the DNA-binding activity of MutL also resulted in higher UvrD helicase activity.

MutH is a member of the type II family of restriction endonucleases and cleaves at hemimethylated GATC sites for excision of mismatch-containing strands. The nicking activity of MutH is stimulated in a mismatch-dependent manner by MutS, MutL and ATP. A structural suggested that the C-terminal helix of MutH might act as a molecular lever through which MutS and MutL communicate and activate MutH (Figure 2C). The nick generated by MutH serves as a point of entry for single-stranded DNA-binding protein and UvrD ⁄ helicase II, whose loading at the nick is facilitated via protein–protein interactions with MutL. Excision of the newly synthesized strand between the nick and the mismatch is carried out by four redundant single-strand DNAspecific exonucleases: the 3¢ fi 5¢ exonucleases ExoI and ExoX and the 5’ → 3’ exonucleases RecJ and ExoVII. DNA polymerase III, single-stranded DNA-binding protein and DNA ligase carry out repair synthesis.

Eukaryotic mismatch repair

 All eukaryotic organisms, including yeast, mouse and human, have MutS homologs (MSHs) and MutL homologs (MLHs). The eukaryotic MMR system has been well conserved during the evolutionary process. However, in contrast to MutS and MutL in bacteria, which function as homodimers, in eukaryotes MSHs and MLHs form heterodimers with multiple proteins. Five highly conserved MSHs (MSH2 to MSH6) are present in both yeast and mammals. MSH1, which is present in mitochondria, exists only in yeast. MSH4 and MSH5 show reproductive tissue-specific expression, and null mutations of these genes do not confer mutator phenotypes because they are involved in meiotic recombination but not postreplication repair. Genetic and biochemical studies have indicated that MSH2 is required for all mismatch correction in nuclear DNA, whereas MSH3 and MSH6 are required for the repair of some distinct and overlapping types of mismatched DNA during replication. These three MutS homologs make two heterodimers: MutSa (MSH2 ⁄MSH6) and MutSb (MSH2 ⁄MSH3). The former plays the major role in recognition of mismatched DNA in eukaryotic MMR. That is, MutSa functions in the repair of base–based mispairs as well as a range of insertion ⁄ deletion loop mispairs, whereas MutSb primarily functions in the repair of insertion ⁄ deletion loop mispairs.

MutL homologs in eukaryotic organisms were identified as genes whose amino DNA Repair acid sequences showed high similarity with prokaryotic MutL proteins, or whose mutation phenotypes were increased levels of postmeiotic segregation (PMS) that resulted from a failure to repair mismatches in meiotic recombination intermediates. There are four homologs of MutL in both yeast and mammals. In a genetic analysis, defects in MLH1 and PMS1 in yeast resulted in more severe mutator phenotypes, reminiscent of those of MSH2 and MSH6, than defects in the two other MutL homologs. Also, MLH1 interacted with the other three MutL homologs in a yeast two-hybrid analysis. Overall, yeast MLH1 ⁄ PMS1 and mammalian MLH1 ⁄ PMS2 heterodimers (each known as MutLa) play a major role in mutation avoidance, and the other two heterodimers of MutL homologs take part in the repair of specific classes of mismatches. The biochemical activities and structure of MutL homologs are closely related to those of prokaryotic MutL proteins, especially in the N-terminal domain. The X-ray crystallographic structure of the conserved N-terminal 40-kDa fragment of human PMS2 resembles that of the ATPase fragment of E. coli MutL.

Extensive genetic studies in yeast have failed to find orthologs of MutH and UvrD in the MMR system, and there may be no homolog of these two proteins in the eukaryotic genome. Therefore, some divergence in the MMR system from strand discrimination and the nicking process might occur between prokaryotes and eukaryotes. A recent increase in our knowledge of the eukaryotic MMR system provides some understanding of this divergence.

In mammalian cell extracts, mismatches provoke initiation of excision at pre existing nicks in exogenous DNA substrates with high efficiency and specificity. The molecular nature of eukaryotic MMR could be assessed using cell extract assays in vitro, and components of the eukaryotic MMR system have been identified with depletion and complementation assays using cell extracts. One protein, identified in this way, is proliferating cell nuclear antigen (PCNA). PCNA is known to function as a processivity factor for replicative polymerase, but some mutations in the PCNA gene result in mutator phenotypes, and its interactions with MSH2 and MLH1, and with MSH6, suggest that it functions in MMR. PCNA has biochemical activity that increases the binding of MutSa to mismatched DNA; the interactions between PCNA and MSH6 are essential for this biochemical activity, which suggests that PCNA might play a role in MMR at the mispair recognition stage. PCNA has been proposed to function in the mismatch recognition stage of MMR by helping MutSa search for mismatched DNA or increasing the mismatchbinding specificity of MutSa. One intriguing point about the role of PCNA in eukaryotic MMR is that the requirement for PCNA depends on the direction of the nick in the in vitro MMR assay. Although PCNA is required for mismatch-provoked excision directed by a 3’ strand break in HeLa nuclear extracts, it is not essential for excision directed by a 5’ nick. Moreover, whereas 3¢ nick-directed excision is completely abolished by the inhibition of PCNA, 5’ nick-directed excision is affected only minimally. Finally, a mismatch-provoked 5’ →3’excision reaction can be reconstituted in a purified system that comprises only MutSa, MutLa, ExoI and replication protein A (RPA), without PCNA, and the process is similar to that observed in nuclear extracts. RPA, the eukaryotic single-stranded DNA-binding protein, has been shown to enhance excision and stabilize excision intermediates in crude fractions.

Genetic studies in yeast, and biochemical studies of MMR activity in cell extracts, indicate that eukaryotes use a mechanism similar to prokaryotes, with both 3’ fi 5’ and 5’ → 3’ exonuclease activities for mismatch correction. ExoI, a 5’ → 3’ exonuclease, was found to play a role in mutation avoidance and mismatch repair in yeast, and its physical interaction with MSH2 and MLH1 also support a role in MMR. Intriguingly, the mammalian ExoI was reported to be involved in both 5’- and 3’ nick-directed excision in extracts of mammalian cells, but how ExoI can have a 3’ → 5’ exonuclease activity was unclear. Recent research by the Modrich group provides a plausible answer to this question. They reconstituted mismatch-provoked excision, directed by a strand break located either 3; or 5’ to the mispair, in a defined human system using purified human proteins. In the presence of the eukaryotic clamp loader replication factor C (RFC) and PCNA, 3’ → 5’ excision was sup ported by MutSa, MutLa, ExoI and RPA. Moreover, RFC and PCNA act to suppress 5’ → 3’ excision when the strand break that directs hydrolysis is located 3’ to the mismatch, which suggests that the polarity of mismatch-provoked excision by ExoI is regulated by PCNA and RFC. Once the strand is excised beyond the mismatch, DNA resynthesis occurs by the activity of polymerase d in the presence of PCNA and RPA. The remaining nick is then sealed by an as-yet-unidentified ligase, completing the repair process.

MMR proteins in the DNA damage response The involvement of MMR proteins in the DNA damage response first became apparent when it was discovered that MMR-defective bacterial and mammalian cells are resistant to cell death caused by alkylating agents. MMR-deficient cells are also resistant to other DNA-damaging agents, including methylation agents, cisplatin and UV radiation. Subsequent studies on the roles of MMR proteins in response to DNA damage in normal cells showed that N-methylN’-nitro N-nitrosoguanidine, an alkylating agent, triggers MMR dependent G2 ⁄M arrest, which is followed by the induction of MMR-dependent apoptosis.

The role of MMR proteins in response to DNA damage can be inferred from the interactions of MMR proteins with the tumor suppressor protein, p53, and p53-related proteins. p53 acts as a major point in a complex network that responds to diverse cellular stresses, including DNA damage. Once stabilized and activated by genotoxic stress, p53 can either activate or repress a wide array of different gene targets by binding to their promoter regions, which in turn can regulate cell cycle, cell death and other outcomes. The p53 homologs p63 and p73 induce p53-independent apoptosis as well as affect trans-activation of certain target genes by p53. Treatment of human cells with methylating agents results in phosphorylation of p53 and induction of apoptosis, a response that depends on the presence of functional hMutSa and hMutLa. UVB-induced apoptosis is significantly reduced in MSH2-deficient cells, and it correlates with decreased activation of p53, which suggests that MSH2 may act upstream of p53 to induce post-UVB apoptosis. Cisplatin-caused DNA damage increases the stability of p73, which induces apoptosis that is dependent on functional hMLH1 protein. Moreover, cisplatin stimulates the interaction between PMS2 and p73, which is required for the activation of p73 and subsequent induction of apoptosis. PMS2 and p73 can also interact with each other, independently of MLH1, suggesting that MMR proteins have specific roles in the DNA damage response. Taken together, these reports indicate that MMR proteins may play roles in multiple steps of the DNA damage response, as damage sensors and adaptors of the pathways (Figure 4).

Fig4. A simplified model of DNA damage response pathways that are dependent on mis match repair (MMR) proteins.

The roles of MMR proteins in the response to DNA damage are further supported by the failure of MMR mutants to trigger G2 ⁄M arrest in response to the methylator N-Methyl-N-nitro-N-nitrosoguanidine and similar alkylators. The G2 ⁄M checkpoint prevents cells from initiating mitosis when they experience DNA damage during G2, or when they progress into G2 with unrepaired damage incurred during the previous S or G1 phases. A cell line lacking hMLH1 expression and an inducible hMLH1 expression system showed that methylation-induced G2 ⁄M arrest requires a full complement of hMLH1 (expression level similar to that of the wild type), whereas MMR proficiency was restored, even at low hMLH1 concentrations (~ 10% of wild-type expression), suggesting that these two responses are carried out by different genetic pathways. The components that transduce the G2 ⁄M checkpoint signal pathway, such as ataxia telangiectasia mutated (ATM), ATM and Rad3-related (ATR), checkpoint kinase 1 (Chk1) and checkpoint kinase 2 (Chk2), are activated in the MMR system-dependent G2 ⁄M arrest induced by DNA methylation. ATR and Chk1 pathways are essential for this response. The mitogenactivated protein (MAP) kinase, p38a, is activated in MMR-proficient cells exposed to the methylating agent, temozolomide, but not in MLH1 knockdown cells, suggesting that the p38 MAP kinase pathway links the MMR system to the G2 ⁄M checkpoint. The interaction between MMR proteins and checkpoint proteins also suggests direct roles for MMR proteins in the DNA damage response. Both in vitro and in vivo approaches show that MSH2 binds to Chk1 and Chk2, that MLH1 associates with ATM and that these interactions are enhanced after treatment with a methylating agent. MSH2 protein physically interacts with ATR in the damage response to DNA methylation, and their interaction is required for the phosphorylation of Chk1. ATR also serves as a haploinsufficient tumor suppressor in MMR-deficient cells, suggesting the genetic interaction of these proteins. Taken together, these findings suggest that MMR proteins function early in the pathway that leads from DNA methylating agents to G2 ⁄M arrest (Figure 4).

MMR proteins bind to damaged DNA and recruit various signal-transducing kinases, including ataxia telangiectasia mutated (ATM), ATM and Rad3-related (ATR), and checkpoint kinase 1 ⁄ checkpoint kinase 2 (Chk1 ⁄ Chk2). They in turn stabilize and activate p53, a key component in DNA damage responses, such as cell cycle checkpoint activation and programmed cell death (apoptosis). p73, a p53 homolog, is also a transducer of the MMR protein-dependent DNA damage response, and postmeiotic segregation 2 (PMS2) is known to bind and stabilize p73. The p38 mitogen-activated protein (MAP) kinase pathway connects MMR proteins and p53 ⁄ p73 in this pathway. c-Abl is a tyrosine kinase that acts upstream of p73 and stabilizes it.

The molecular mechanism of the involvement of MMR proteins in various DNA damage responses is unclear. Given the original function of the MMR system in detecting and repairing errors that occur during replication, the MMR protein complex could serve as a sensor for DNA damage. A large complex, named BRCA1-associated genome surveillance complex, which includes tumor suppressors and the MMR ⁄ DNA damage-repair proteins MSH2, MSH6, MLH1, ATM, Bloom’s syndrome, and RAD50– MRE11–NBS1, has also been suggested to be a possible sensor for DNA damage. The roles of MMR proteins in the DNA damage response may not be simple from the viewpoint of their various relationships with other regulators of the DNA damage response, especially with ATM and p53. For instance, hMLH1 and hPMS2 were identified as direct target genes of p53. Cisplatin induces the accumulation of hPMS1, hPMS2 and hMLH1 through ATM-mediated protein stabilization, and the induced level of these MMR proteins is important for the phosphorylation of p53 by ATM in the response to DNA damage. MMR proteins and p53 therefore may act as a kind of positive feedback regulation for the DNA damage response, or a more complicated network may regulate their activity and expression.

MMR proteins in antibody diversification

 In addition to the initial generation of antibody diversity by gene rearrangement during B-cell development, specific antigen recognition triggers a second wave of antibody diversification through somatic hypermutation (SHM) and class switch recombination (CSR). SHM introduces multiple single-nucleotide substitutions into variable (V) regions of immunoglobulin genes and CSR is a region-specific intrachromosomal recombination that replaces the Cl form of the immunoglobulin (Ig) heavy chain constant region (CH) gene with other CH genes, resulting in a switch of the Ig isotype from IgM to IgG, IgE, or IgA. The molecular processes of SHM and CSR, and the proteins involved in these processes, have been investigated in detail over the last few years. Advances in gene targeting techniques have led to the availability of mice with loss-of-function mutations in MMR genes, and recent studies using these mice have suggested that MMR proteins are directly involved in antibody diversification. MSH2-deficient mice accumulated fivefold fewer mutations in the V region of antibody genes. MSH6 deficiency caused similar effects, but MSH3 deficiency did not, suggesting that MutSa plays an essential role in SHM. Similarly, mice with lossof-function mutations in MSH2 or MSH6 have a decreased frequency of CSR, but those with MSH3 do not. Mice carrying a mutation in the MSH2 ATPase domain are deficient in SHM and CSR, suggesting that the ATPase activity of MSH2 is essential for antibody diversification. It will be interesting to understand how MMR proteins are involved in the processes of SHM and CSR, which require the induction of mutations.

Both SHM and CSR start with the activity of activation-induced cytidine deaminase (AID), which is a homolog of the RNA editing enzyme, but is known to deaminate dC to dU subsequently in ssDNA. Transcription of the Ig gene in the V and switch (S) regions is required for SHM and CSR, respectively, because AID deaminates cytidine residues in single-stranded DNA located in the transcription bubble of the V and S regions, (Figure 5). AID-induced mutations of cytidine explain some SHM and mutations in CSR, but up to half of the mutations of the V and S regions are independent of AID. Phenotypic analyses of MSH2- and MSH6- defective mice showed that the spectra of SHM were different in these mice than in wild-type mice, indicating that MSH2 and MSH6 are required for mutations at AT base pairs during SHM and CSR. These results suggested that mutations in SHM and CSR are achieved in two steps: in the first step, AID generates mutations in GC base pairs, and in the second step, the MMR system is recruited to the mismatched DNA and resynthesizes the DNA strand with the help of an error-prone polymerase, such as pol g (Figure 5). This model is supported by a report that MSHa not only binds to a U: G mispair, but also physically interacts with DNA polymerase g and functionally stimulates its catalytic activity. Moreover, the phenotypes of mice mutant for ExoI are similar to those of MSH2– ⁄ – mice, with reduced SHM and CSR, and ExoI and MLH1 physically interact with mutating variable regions.

Fig5. A model of somatic hypermutation that is dependent on the mismatch repair (MMR) protein.

(A) During transcription of the immunoglobulin gene in the variable (V) region, activation-induced cytidine deaminase (AID) deaminates cytidine residues in single stranded DNA to produce UG mismatches. (B) MutSa and MutLa are recruited to the mismatched DNA, and activate ExoI. (C) The gaps generated by the activity of ExoI are refilled by error-prone DNA polymerase g, resulting in mutations in AT base pairs. (D) The diversity of the V regions of antibody genes is thus accomplished by the formation of mutations by a mechanism that depends on MMR proteins.

اخر الاخبار

اشترك بقناتنا على التلجرام ليصلك كل ما هو جديد